Bmi-1 induces radioresistance by suppressing senescence in human U87 glioma cells

Oncology Letters

Volumn 8, Issue 6, 2014, Pages 2601-2606

  Ye, Lan ^a   Wang, Cuihong ^a   Yu, Guanying ^b   Jiang, Yuhua ^a   Sun, Dianshui ^a   Zhang, Zaiyun ^a   Yu, Xiaoming ^a   Li, Xiaomei ^a   Wei, Wei ^a   Liu, Ping ^a   Cheng, Jian ^a   Du, Bin ^b   Hu, Likuan ^c  

^a THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

^b JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

Bmi 1; Glioma; Radiation; Senescence

Indexed keywords

BETA GALACTOSIDASE; BMI1 PROTEIN; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; PROPIDIUM IODIDE;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER RADIOTHERAPY; CELL AGING; CELL CULTURE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; GLIOMA CELL; GLIOMA CELL LINE; HUMAN; HUMAN CELL; RADIATION EXPOSURE; RADIOSENSITIVITY; SENESCENCE; UPREGULATION; WESTERN BLOTTING; X RAY;

EID: 84908047127     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2606     Document Type: Article

References (34)

1. Louis DN, Ohgaki H, Wiestler OD, et al: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114: 97-109, 2007.
2. Ohgaki H, Dessen P, Jourde B, et al: Genetic pathways to glioblastoma: a population-based study. Cancer Res 64: 6892-6899, 2004.
3. Cancer Genome Atlas Research Network: Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061-1068, 2008.
4. Ohgaki H and Kleihues P: Genetic alterations and signaling pathways in the evolution of gliomas. Cancer Sci 100: 2235-2241, 2009.
5. Lee JJ, Kim BC, Park MJ, et al: PTEN status switches cell fate between premature senescence and apoptosis in glioma exposed to ionizing radiation. Cell Death Differ 18: 666-677, 2011.
6. Quick QA and Gewirtz DA: An accelerated senescence response to radiation in wild-type p53 glioblastoma multiforme cells. J Neurosurg 105: 111-118, 2006.
7. Nam HY, Han MW, Chang HW, et al: Radioresistant cancer cells can be conditioned to enter senescence by mTOR inhibition. Cancer Res 73: 4267-4277, 2013.
8. Hwang ES, Yoon G and Kang HT: A comparative analysis of the cell biology of senescence and aging. Cell Mol Life Sci 66: 2503-2524, 2009.
9. Chowdhury M, Mihara K, Yasunaga S, Ohtaki M, Takihara Y and Kimura A: Expression of Polycomb-group (PcG) protein BMI-1 predicts prognosis in patients with acute myeloid leukemia. Leukemia 21: 1116-1122, 2007.
10. Vonlanthen S, Heighway J, Altermatt HJ, et al: The Bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. Br J Cancer 84: 1372-1376, 2001.
11. Zhang FB, Sui LH and Xin T: Correlation of Bmi-1 expression and telomerase activity in human ovarian cancer. Br J Biomed Sci 65: 172-177, 2008.
12. Song LB, Li J, Liao WT, et al: The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J Clin Invest 119: 3626-3636, 2009.
13. Guo BH, Feng Y, Zhang R, et al: Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer. Mol Cancer 10: 10, 2011.
14. Dhawan S, Tschen SI and Bhushan A: Bmi-1 regulates the Ink4a/Arf locus to control pancreatic beta-cell proliferation. Genes Dev 23: 906-911, 2009.
15. Bruggeman SW, Hulsman D, Tanger E, et al: Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma. Cancer Cell 12: 328-341, 2007.
16. Glinsky GV, Berezovska O and Glinskii AB: Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest 115: 1503-1521, 2005.
17. Häyry V, Tynninen O, Haapasalo HK, et al: Stem cell protein BMI-1 is an independent marker for poor prognosis in oligodendroglial tumours. Neuropathol Appl Neurobiol 34: 555-563, 2008.
18. Li J, Gong LY, Song LB, et al: Oncoprotein Bmi-1 renders apoptotic resistance to glioma cells through activation of the IKK-nuclear factor-kappaB pathway. Am J Pathol 176: 699-709, 2010.
19. Taylor LP: Diagnosis, treatment, and prognosis of glioma: five new things. Neurology 75: S28-S32, 2010.
20. Stupp R, Mason WP, van den Bent MJ, et al; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996, 2005.
21. Clarke J, Butowski N and Chang S: Recent advances in therapy for glioblastoma. Arch Neurol 67: 279-283, 2010.
22. Stupp R, Hegi ME, Mason WP, et al; European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group: Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10: 459-466, 2009.
23. Xie C, Wang H, Cheng H, Li J, Wang Z and Yue W: RAD18 mediates resistance to ionizing radiation in human glioma cells. Biochem Biophys Res Commun 445: 263-268, 2014.
24. Liu P, Huang Z, Chen Z, et al: Silver nanoparticles: a novel radiation sensitizer for glioma? Nanoscale 5: 11829-11836, 2013.
25. Naidu MD, Mason JM, Pica RV, Fung H and Peña LA: Radiation resistance in glioma cells determined by DNA damage repair activity of Ape1/Ref-1. J Radiat Res 51: 393-404, 2010.
26. Jendrossek V: The intrinsic apoptosis pathways as a target in anticancer therapy. Curr Pharm Biotechnol 13: 1426-1438, 2012.
27. Dewey WC, Ling CC and Meyn RE: Radiation-induced apoptosis: relevance to radiotherapy. Int J Radiat Oncol Biol Phys 33: 781-796, 1995.
28. Schmitt CA: Cellular senescence and cancer treatment. Biochim Biophys Acta 1775: 5-20, 2007.
29. Roninson IB: Tumor cell senescence in cancer treatment. Cancer Res 63: 2705-2715, 2003.
30. Li Y, Hu J, Guan F, et al: Copper induces cellular senescence in human glioblastoma multiforme cells through downregulation of Bmi-1. Oncol Rep 29: 1805-1810, 2013.
31. Jacobs JJ, Kieboom K, Marino S, DePinho RA and van Lohuizen M: The oncogene and Polycomb-group gene Bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397: 164-168, 1999.
32. Jiang L, Li J and Song L: Bmi-1, stem cells and cancer. Acta Biochim Biophys Sin (Shanghai) 41: 527-534, 2009.
33. Hara E, Smith R, Parry D, Tahara H, Stone S and Peters G: Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol 16: 859-867, 1996.
34. Molofsky AV, Pardal R, Iwashita T, Park IK, Clarke MF and Morrison SJ: Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 425: 962-967, 2003.